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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S284Purpose: Chondroitin sulfate (CS) is one the most usedmolecules in the
management of osteoarthritis (OA). In this study, we performed
a microarray analysis and identiﬁed a differential expression proﬁle
between control and IL-1b stimulated synovial ﬁbroblast cells cultures.
In a second step, we investigated the effects of CS on this gene
expression proﬁle.
Methods: OA synovial specimens were obtained from 12 patients
undergoing knee replacement. At the surgery time, the synovial
membrane was dissected. Synovial ﬁbroblast cells (SFC) were enzy-
matically isolated and used after four passages (P4). SFC were pre-
treated 1 hour with highly puriﬁed bovine CS (200 mg/ml, Bioibérica
S.A., Barcelona, Spain) before treatment with IL-1b (1 ng/ml) for 24
hours. Total RNA was extracted using the RNeasy Mini Kit. RNA purity
and quality were evaluated using the Experion RNA StdSens Analysis kit
(Bio-rad Laboratories). Gene expression proﬁling was performed using
Illumina's multi-sample format Human HT-12 BeadChip (Illumina Inc.).
Differential analysis was performed with the BRB array tools software.
Class comparison test between control (Ctl) and interleukin (IL)-1b
conditions, Ctl and Ctl/CS and IL-1b and IL-1b/CS conditions was based
on paired t-test where Ctl and IL-1b, Ctl and Ctl/CS and IL-1b and IL-1b/
CS were paired for each patient. The biological relevance of up- and
down-regulated genes was analysed with Ingenuity Pathways Analysis
(Ingenuity Systems). Probes with a p-value below 0.001 were chosen
and classiﬁed as up- or down-regulated ones.
Results: 3308 genes were identiﬁed as differentially expressed genes
between Ctl and IL-1b conditions. We observed a differential proﬁle of
expression of major pathways involved in OA pathogenesis. The key
identiﬁed pathways were related to inﬂammation, complement
cascade, angiogenesis, cartilage catabolism and anabolism and Wnt
signaling. In the inﬂammatory network, the most upregulated cyto-
kines were IL-8 and IL-6 with a fold change of 156.25 and 58.8
respectively. We also identiﬁed several chemokines, enzymes and
metallothioneins (MTs). Complement factor B (CFB) and complement
component 3 (C3) are two factors upregulated in the inﬂammatory
complement cascade. We also identiﬁed some genes implicated in the
angiogenesis pathway. The most upregulated was Stanniocalcin 1
(STC1) with a fold change of 9.09. The differential expression of inter-
mediates involved in both cartilage anabolism and catabolism was
revealed by the IL-1b stimulation, showing an imbalance in favour of
catabolism. MMP-3 was largely upregulated (fold change of 62.5). Wnt
5A and low density lipoprotein receptor-related protein (LRP8) were
signiﬁcantly upregulated while frizzled homolog 2 (FZD2) and dickkopf
homolog 3 (DKK3) were downregulated in the Wnt signaling pathway.
We next performed a class comparison test between Ctl and Ctl/CS in
one hand and IL-1b and IL-1b/CS on the other hand. 660 genes were
identiﬁed as differentially expressed between Ctl and Ctl/CS conditions
while 241 genes were identiﬁed between IL-1b and IL-1b/CS. Among
them, our attention was focused on two genes upregulated in the
presence of CS: lysyl oxidase-like 4 (LOXL4) and claudin 11 (CDLN11),
two genes that negatively regulate cell invasion.
Conclusions: We here evidenced in synovial ﬁbroblast cells the
modulation of gene expression following IL-1b stimulation. We also
demonstrated the modulatory effects of CS on gene expression and
isolated several CS-modulated genes of interest such as LOXL4 and
CDLN11, which could constitute new mechanisms of action of the
molecule and contribute to explain the symptomatic efﬁcacy of CS in
the treatment of OA.
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SYNOVIAL WNT AND WISP1 EXPRESSION INDUCES EXPRESSION OF
CARTILAGE-DEGRADING METALLOPROTEINASES IN THE SYNOVIUM
M. van den Bosch, A. Blom, A. van Erp, F. van de Loo, E. Blaney
Davidson, P. van der Kraan, P. van Lent, W. van den Berg. Radboud
Univ. Nijmegen Med. Ctr., NCMLS, Nijmegen, The Netherlands
Purpose: Although many osteoarthritis (OA) patients show signiﬁcant
synovial involvement, consequences are largely unknown. Previously, we
foundstrongupregulationofWnts2band16andWnt-1 inducedsignaling
protein 1 (WISP1), a downstream protein of canonical Wnt signaling, in
knee joints in twomurine OAmodels. Wnt signaling has been implicated
inOA incidence andmodulation of the b-cateninpathway leads to OA-like
changes in cartilage.However, the role of the synovium in the induction of
OA pathology under the inﬂuence of Wnt signaling is unclear. In the
present study we investigated the potential of Wnt signaling to increase
the expression of cartilage-degrading enzymes in the synovium.Methods: Pathway analysis of microarray data from the synovium of
a collagenase-induced OA mouse model was done using DAVID soft-
ware. In vivo synovial overexpression of genes from the canonical Wnt
signaling pathway was achieved by intra-articular injection of adeno-
viral vectors. Joint pathology was assessed by histology at several time
points after injection. Gene expression was analyzed by qPCR. Human
OA synovial specimens were collected from joint replacement surgery
and either stimulated or used for outgrowth of OA ﬁbroblasts.
Results: Pathway analysis using DAVID showed that the Wnt signaling
pathway was enriched in the synovium during experimental OA. To
determine the effects ofWnt signaling on synovial tissue, we stimulated
human OA synovial specimen with Wnt3a or WISP1, which resulted in
increased expression of matrix metalloproteinase (MMP)3, MMP9 and
MMP13, whereas expression of tissue inhibitor of metalloproteinase
(TIMP)1 and 3 was not altered. Next, we investigated which cell-type in
the synovium may cause the increased MMP expression. Stimulation of
human synovial OA ﬁbroblasts with Wnt3a increased the expression of
bothMMP3 andMMP13, whereas stimulation of these cells withWISP1
led to an upregulation of MMP3. Stimulation of human THP-1 cells with
Wnt3a resulted in highly increased expression of MMP3, MMP9 and
MMP13. Stimulation with WISP1 led to increased expression of MMP3.
Expression levels of TIMP1 and 3 were not altered. To determine if
synovial overexpression of members of the Wnt signaling pathway
leads to cartilage damage in vivo, we injected adenoviral vectors for
Wnt8a, Wnt16 and WISP1 into murine knee joints. These vectors
speciﬁcally target synovial cells, due to their size. 7 days after over-
expression, we found a signiﬁcant induction of OA pathology at the
medial margin of the medial tibial plateau, a preferential site for
damage in experimental OA. Lesions were found in 92% (n¼12) of the
knee joints afterWnt8a overexpression compared to 17% (N¼12) for the
control virus and 80% (N¼5) for Wnt16 overexpression, but only 20%
(N¼5) for the control virus. In addition, overexpression of WISP1 led to
signiﬁcantly increased cartilage damage after 7 days.
Conclusions: Canonical Wnts produced in the synovium may play an
important role in OA pathology. Stimulation of human OA synovium
with Wnts and WISP1 increases the expression of MMPs. Fibroblasts
and macrophages showed comparable patterns of MMP induction. In
addition, synovium speciﬁc overexpression of Wnt signaling members,
as is found in experimental OA, induces cartilage damage in vivo. This
underlines synovial Wnt/WISP1 expression to be a potential target for
OA therapy.
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EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION
PROFILE IN THE INFLAMED SYNOVIAL MEMBRANE
C. Lambert y, J.-E. Dubuc z, E. Montell x, J. Vergés x, Y. Henrotin y. yBone
and Cartilage Res. Unit, Univ. of Liège, Liège, Belgium; zOrthopaedic
Dept., Cliniques Univ.ires St Luc, Brussels, Belgium; x Pre-Clinical R&D
Area, Pharma Sci. Div., Bioibérica, S.A, Barcelona, Spain
Purpose: The aim of the present work was to identify the differentially
expressed genes between the inﬂammatory (I) and normal/reactive (N/
R) synovial areas using a unique ex vivo culture model. In a second step,
we investigated the genetic modulatory effects of chondroitin sulfate
(CS) in this model.
Methods: Synovial cells (SC) were isolated from OA synovial specimens
obtained from 12 patients undergoing knee replacement. The inﬂam-
matory status of the synovial membranewas characterized according to
macroscopic criteria. At the surgery time, the synovial membrane was
dissected and biopsies from N/R and I areas cultured separately for
a period of 7 days in the absence or in the presence of highly puriﬁed
bovine CS (200 mg/ml, Bioibérica S.A., Barcelona, Spain). Total RNA was
extracted using the RNeasy Mini Kit. RNA purity and quality were
evaluated using the Experion RNA StdSens Analysis kit (Bio-rad Labo-
ratories). Gene expression proﬁling was performed using Illumina's
multi-sample format Human HT-12 BeadChip (Illumina Inc.). Differen-
tial analysis was performed with the BRB array tools software. Class
Comparison test between N/R and I conditions, N/R and N/R-CS
conditions and I and I-CS conditions was based on paired t-test where
N/R and I, N/R and N/R-CS and I and I-CS were paired for each patient.
The biological relevance of up- and down-regulated genes was analysed
with Ingenuity Pathways Analysis (Ingenuity Systems).
Results: From among 47000 probes, 18253 were ﬁltered out. Probes
with a p-value below than 0.005 were chosen and classiﬁed as up- or
down-regulated ones. By this way, 465 differentially expressed genes
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appear differentially expressed. The interferon alpha-inductible protein
6 (IFI6) was the most up-regulated. We also identiﬁed the hydrox-
ysteroid (11-beta) dehydrogenase 1 (HSD11B1), the cathepsin K (CTSK),
the chemokine (C-X-C motif) ligand 1 (CXCL1) and the EBV-induced G-
protein coupled receptor 2 (EBI2). The differential expression of inter-
mediates involved in angiogenesis pathway was also revealed between
N/R and I areas. Among them, R-spondin-3 (RSPO3), the secreted
phopshoprotein 1 (SPP1) and aquaporin 9 (AQP9) were up-regulated
whereas ADAMTS1 was down-regulated. Finally, in the Wnt signaling,
RSPO3 was up-regulated unlike dickkopf homolog 3 (DKK3) which was
in turn down-regulated. We next performed a class comparison test
between N/R and N/R-CS in one hand and between I and I-CS the other
hand. 489 genes were identiﬁed as differentially expressed genes
between N/R and N/R-CS conditions while 219 genes were identiﬁed
between I and I-CS conditions. In this latter, our attention was focused
on the down-regulated genes. Among them, we identiﬁed a number
implicated in angiogenesis and cell migration pathways. Thus, the
endothelial cell-speciﬁc molecule-1 (ESM1), the Transmembrane-4-L-
six-family-1 (TM4SF1), the 50-Ectonucleotidase (NT5E) and the growth
arrest-speciﬁc gene 6 (GAS6) were down-regulated by CS.
Conclusions: Our work demonstrates the differential gene expression
proﬁle between paired inﬂammatory and normal/reactive areas of
synovial membrane as well as the modulatory effects of CS on gene
expression in the inﬂammatory areas, especially regarding genes
involved in both angiogenesis and cell migration.
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INVESTIGATION OF POTENTIAL NEW TARGETS FOR THE DIAGNOSIS
AND/OR THE TREATMENT OF OSTEOARTHRITIS
C. Lambert y, J.-E. Dubuc z, E. Montell x, J. Vergés x, C. Munaut k, A.
Noël k, Y. Henrotin y. yBone and Cartilage Res. Unit, Univ. of Liège, Liège,
Belgium; zOrthopaedic Dept., Cliniques Univ.ires St Luc, Brussels,
Belgium; x Pre-Clinical R&D Area, PharmaSci. Div., Bioibérica, S.A,
Barcelona, Spain; k Lab. of Tumor and Dev.al Biology, GIGA-Cancer, Inst.
of Pathology, Univ. of Liège, Liège, Belgium
Purpose: Synovial inﬂammation plays a key role in the pathophysiology
process of osteoarthritis (OA). We have previously compared the gene
expression pattern of synovial cells isolated from inﬂammatory (I) or
normal/reactive (N/R) areas of a synovial membrane harvested from the
same OA patient. We identiﬁed a large number of mediators belonging
to key pathways involved in OA pathogenesis. The aim of this study was
to validate different potential new targets for the diagnosis and/or the
treatment OA.
Methods: Synovial cells (SC) were isolated from synovial specimens
obtained from OA patients undergoing knee replacement. The inﬂam-
matory status of the synovial membranewas characterized according to
macroscopic criteria. The biopsies from N/R and I areas were cultured
separately for a period of 7 days. Microarray gene expression proﬁling
between N/R and I areas was performed. The biological relevance of up-
and down-regulated genes was analyzed with Ingenuity Pathways
Analysis. Western blot and immunohistochemistry conﬁrmed the
identiﬁed genes most differentially expressed in the key pathways. The
production of the triggering receptor expressed on myeloid cells-1
(TREM1), the alarmin S100 calcium binding protein A9 (S100A9), the
wingless-type MMTV integration site family, member 5A (Wnt-5A) and
the stanniocalcin 1 (STC1) were evaluated by Western blot. S100A9,
hyaluronan synthase-1 (HAS1) and STC1 expression and localization
were investigated by immunohistochemistry.
Results: 896 genes differentially expressed in N/R and I areas were iden-
tiﬁed. The key pathways were related to inﬂammation, cartilage metab-
olism,Wnt signaling and angiogenesis. In the inﬂammatory gene pattern,
TREM1 and S100A9 were strongly upregulated. We validated the
production of these proteins in OA synovial biopsies by Western blot.
TREM1 and S100A9 were increased in I compared to N/R synovial cells
culture. S100A9 was observed in the perivascular area and in sublining
cells in I synovial biopsies, but not in N/R biopsies. An increased staining
was also observed in the intima lining layer of I when compared to N/R
biopsies. The most upregulated anabolism enzyme in I synovial biopsies
was HAS1. Using immunohistochemistry, we observed in I areas an
increase of the HAS1-positive cells mainly in the intima lining. We also
studied the protein production of Wnt-5A, the most upregulated inter-
mediate of Wnt signaling pathway. The protein level was increased in I
compared toN/R areas. Finally, in the angiogenesis pathway, one themostupregulated genewas STC1. A signiﬁcant increase of STC1 productionwas
observed in I areas compared toN/R areas byWestern blot. This resultwas
also supported by the immunohistochemical analysis. In I area, the
staining for STC1 was more intense in perivascular and sublining cells.
Conclusions: Synovial membrane inﬂammation is a key target for OA
treatments. In this work, we have identiﬁed proteins involved in the
synovitis pathways like angiogenesis, cells inﬁltration and matrix
remodeling. These proteins could be targeted by drugs and used as
companion biomarkers for evaluating their efﬁcacy. Although qualita-
tive, our results could also yield to the identiﬁcation of markers of the
disease. This investigation has to be further pursued.
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CHONDROITIN SULFATE REGULATES TWO ANTI-ANGIOGENIC
FACTORS IN HUMAN OSTEOARTHRITIC SYNOVIAL FIBROBLASTS
J.Martel-Pelletier y, F.Mineau y, E.Montell z, J. Vergés z, J.-P. Pelletier y. yUniv.
of Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada; z Pre-Clinical
R&D Area, Pharma Sci. Div., Bioibérica S.A., Barcelona, Spain
Purpose: The symptomatic slow acting drug for osteoarthritis (SYSA-
DOA), chondroitin sulfate, has attracted much interest as a biological
agent for its use in the effective relief of disease symptoms. This is likely
due to its capacity for reducing joint swelling and effusion which may
be explained by its anti-inﬂammatory effects. However, the factors
involved in this latter effect are yet to be fully identiﬁed. Angiogenesis is
an important event of synovial inﬂammation and it is suggested to
contribute to the joint symptoms in OA. We thus elected to determine
the effect of chondroitin sulfate on the levels of two well-known anti-
angiogenic factors previously demonstrated to be involved in OA: the
vascular endothelial growth inhibitor (VEGI) and thrombospondin-1
(TSP-1). Furthermore, we explored the signaling pathways by which
chondroitin sulfate exerts its effects on these factors.
Methods: Human OA synovial ﬁbroblasts were obtained from sequen-
tial enzymatic digestion. Cells were pre-incubated for 18 hours with
chondroitin sulfate (200 mg/ml; CSbBio-Active, Bioibérica, Spain) and
then incubated with IL-1ß (10 and 100 pg/ml) in the absence or pres-
ence of chondroitin sulfate for increasing periods of time. Cells were
processed for protein expression determination using quantitative PCR,
protein production using ELISAs, and for signaling pathways using
Western blotting.
Results: Both VEGI and TSP-1 expression were dose-dependently
decreased by IL-1ß at both concentrations tested. Chondroitin sulfate
signiﬁcantly increased the expression and synthesis levels of the two
anti-angiogenic factors VEGI and TSP-1 under basal conditions as well
as under IL-1ß treatment. The signaling pathways through which
chondroitin sulfate increased the levels of VEGI and TSP-1 in the pres-
ence of IL-1ß were further investigated by measuring the phosphory-
lated levels of three MAP kinases, namely ERK1/2, p38, and JNK, and
other cascades including NF-kB, Akt, and STAT-3. Data revealed that the
effects occurred through two main pathways, Akt and STAT-3. Addi-
tional experiments with speciﬁc inhibitors of Akt phosphorylation (SH-
6, Santa Cruz) and STAT-3 translocation (Stat3 inhibitor VIII, 5,15-DPP,
Santa Cruz) conﬁrmed these data.
Conclusions: This study showed that chondroitin sulfate increased the
levels of two important anti-angiogenic factors, which could provide
a possible new mechanism of action of this SYSADOA. These ﬁndings
may explain, in part, how chondroitin sulfate reduces the severity of
synovitis in knee OA. In addition, these data bring to light that anti-
angiogenic factors could be targeted as a speciﬁc therapeutic approach
in disease modifying OA drug development.
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GENE EXPRESSION ANALYSIS OF OA SYNOVIUM REVEALS ELEVATION
OF TGF-ß RESPONSIVE GENES IN OA-RELATED FIBROSIS
D.F. Remst y, A.B. Blom y, E.N. Blaney Davidson y, E.L. Vitters y, R.A.
Bank z, W.B. van den Berg y, P.M. van der Kraan y. yRadboud Univ.
Nijmegen Med. Ctr., Nijmegen, The Netherlands; zUniv. Med. Ctr.
Groningen, Groningen, The Netherlands
Purpose: Synovial ﬁbrosis is a major contributor to joint stiffness in
osteoarthritis (OA). We have previously shown that TGF-b, which is
elevated inOA,playsakey role inonsetandpersistenceof synovialﬁbrosis.
Blocking TGF-b as a therapeutic intervention for ﬁbrosis in OA is not an
option, as TGF-b is crucial for cartilage maintenance and repair. To over-
come this problem and ﬁnd a target that can be blocked we wanted to
